Successful early use of anti‐SARS‐CoV‐2 monoclonal neutralizing antibodies in SARS‐CoV‐2 infected hematological patients – A Czech multicenter experience
暂无分享,去创建一个
R. Hájek | P. Žák | Z. Král | J. Mayer | J. Valka | P. Jindra | P. Cetkovský | B. Víšek | T. Szotkowski | J. Novák | L. Stejskal | B. Weinbergerová | M. Čerňan | I. Demel | T. Kabut | Flóra Kovácsová | Ivo Demel | Flora Kovacsova
[1] A. Barać,et al. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) , 2021, Journal of Hematology & Oncology.
[2] A. Venkatakrishnan,et al. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. , 2021, The Journal of clinical investigation.
[3] P. Frankel,et al. SARS-CoV-2 Specific Monoclonal Antibody for the Treatment of Mild-to-Moderate COVID-19 in Cancer Patients: A Single-center Experience , 2021, Journal of Infectious Diseases.
[4] X. de Lamballerie,et al. Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia , 2021, British Journal of Haematology.
[5] L. Gerber,et al. Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] R. Andino,et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains , 2021, Nature.
[7] Christopher C. Nabors,et al. Casirivimab-Imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: an Early Experience. , 2021, Transplantation.
[8] Christopher C. Nabors,et al. Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience , 2021, Clinical transplantation.
[9] John D. Davis,et al. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 , 2020, The New England journal of medicine.
[10] W. Wood,et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients , 2020, Blood.
[11] D. Skovronsky,et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 , 2020, The New England journal of medicine.
[12] Carlos Del Rio,et al. Mild or Moderate Covid-19. , 2020, The New England journal of medicine.